Citation Impact
Citing Papers
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
2013 StandoutScience
Metastatic Growth from Dormant Cells Induced by a Col-I–Enriched Fibrotic Environment
2010
Prospective identification of tumorigenic breast cancer cells
2003 Standout
From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression
2003
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
2004 StandoutNobel
ErbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients.
2001
Increase in number of circulating disseminated epithelial cells after surgery for non-small cell lung cancer monitored by MAINTRAC® is a predictor for relapse: A preliminary report
2005
Hallmarks of Cancer: The Next Generation
2011 Standout
Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m 6 A-demethylation of NANOG mRNA
2016 StandoutNobel
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Endogenous human microRNAs that suppress breast cancer metastasis
2008 StandoutNature
Dissecting the metastatic cascade
2004
Clinical Significance of Bone Marrow Micrometastasis Detected by Nested RT-PCR for Keratin-19 in Breast Cancer Patients
2003
Tumor-Cell Homing to Lymph Nodes and Bone Marrow and CXCR4 Expression in Esophageal Cancer
2005
Inflammation and cancer
2002 StandoutNature
β-Catenin regulates expression of cyclin D1 in colon carcinoma cells
1999 StandoutNature
Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma
2010
Prognostic Significance of Occult Bone Marrow Micrometastases of Breast Cancer Detected by Quantitative Polymerase Chain Reaction for Cytokeratin 19 mRNA
2000
Mammaglobin Gene Expression: A Superior Marker of Breast Cancer Cells in Peripheral Blood in Comparison to Epidermal-Growth-Factor Receptor and Cytokeratin-19
2000
The perivascular niche regulates breast tumour dormancy
2013
Detection of Breast Cancer micrometastases in peripheral blood using immunomagnetic separation and immunocytochemistry
2001
Minimal Residual Disease in Bone Marrow and Peripheral Blood of Patients with Metastatic Breast Cancer
2003
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment.
1998
Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer
2003
A real-time quantitative reverse transcriptase polymerase chain reaction (RT–PCR) to detect breast carcinoma cells in peripheral blood
2001
Tumor Cell Dissemination: Emerging Biological Insights from Animal Models and Cancer Patients
2013
Tumor heterogeneity: Causes and consequences
2009
Genetic instabilities in human cancers
1998 StandoutNature
Metastatic Stem Cells: Sources, Niches, and Vital Pathways
2014
The level of CD8 expression can determine the outcome of thymic selection
1992 StandoutNobel
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Evaluation of breast tumour cell contamination in the bone marrow and leukapheresis collections by RT‐PCR for cytokeratin‐19 mRNA
1998
Mechanisms of disseminated cancer cell dormancy: an awakening field
2014
Isolation of rare circulating tumour cells in cancer patients by microchip technology
2007 StandoutNature
Prognostic relevance of urokinase plasminogen activator detection in micrometastatic cells in the bone marrow of patients with primary breast cancer
1997
Models, mechanisms and clinical evidence for cancer dormancy
2007
Significance, detection and markers of disseminated breast cancer cells
2006
Environment-mediated drug resistance: a major contributor to minimal residual disease
2009
Circulating tumour cells in breast cancer
2004
The fate of bone marrow micrometastases in patients with primary breast cancer.
1989
The urokinase-type plasminogen activator system in cancer metastasis: A review
1997 Standout
Prognostic value of bone marrow biopsy in operable breast cancer patients at the time of initial diagnosis: Results of a 20-year median follow-up
1998
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Signaling antibodies in cancer therapy
1999
The microenvironment of the tumour–host interface
2001 StandoutNature
Molecular Biology and Function of CD4 and CD8
1989
Molecular Determinants of Occult Metastatic Tumor Cells in Bone Marrow
2001
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Cancer micrometastases
2009
Adhesion receptors of the immune system
1990 StandoutNature
Monoclonal antibodies as therapeutic agents for cancer
2004
Cytokeratin-Positive Cells in the Bone Marrow and Survival of Patients with Stage I, II, or III Breast Cancer
2000
Parallel progression of primary tumours and metastases
2009
Clinical trials of antibody therapy
2000
Prognostic relevance of cathepsin D detection in micrometastatic cells in the bone marrow of patients with primary breast cancer
1998
The causes and consequences of genetic heterogeneity in cancer evolution
2013 StandoutNature
HIV as the cause of AIDS
1996 StandoutNobel
Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases.
1991
Ineffectiveness of Doxorubicin Treatment on Solitary Dormant Mammary Carcinoma Cells or Late-developing Metastases
2003
Role of Lymphocyte Adhesion Receptors in Transient Interactions and Cell Locomotion
1991
Detection of micrometastatic breast cancer by means of real time quantitative RT‐PCR and immunostaining in perioperative blood samples and sentinel nodes
2003
Does tumour dormancy offer a therapeutic target?
2010
Bone marrow micrometastases in breast cancer patients
1999
Detection of micrometastatic tumor cells in bone marrow of breast carcinoma patients
1991
Bone metastasis: the importance of the neighbourhood
2016
Clonal evolution in cancer
2012 StandoutNature
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001 Standout
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
2001 StandoutNature
Systemic Spread Is an Early Step in Breast Cancer
2008
Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up
1994
Regulation by HIV Rev depends upon recognition of splice sites
1989 StandoutNobel
Immunocytochemical detection of isolated epithelial cells in bone marrow: non-specific staining and contribution by plasma cells directly reactive to alkaline phosphatase
1998
Frequent EpCam protein expression in human carcinomas
2004
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
Cancer-related inflammation
2008 StandoutNature
Clinical Utility of Urokinase-Type Plasminogen Activator and Plasminogen Activator Inhibitor—1 Determination in Primary Breast Cancer Tissue for Individualized Therapy Concepts
2002
The biology of the 17–1A antigen (Ep-CAM)
1999
Micrometastatic Breast Cancer Cells in Bone Marrow at Primary Surgery: Prognostic Value in Comparison With Nodal Status
1996
Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
1995 Standout
Novel approaches to target the microenvironment of bone metastasis
2021
Extracellular matrix: A gatekeeper in the transition from dormancy to metastatic growth
2010
Breast cancer metastasis: markers and models
2005 Standout
Detection of carcinoma cells in the blood of breast cancer patients
2000
Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer
2000
Escape of Human Solid Tumors from T–Cell Recognition: Molecular Mechanisms and Functional Significance
1999
Detection of Surface Antigen 17-1A in Breast and Colorectal Cancer
1999
Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer
1997 StandoutNobel
Drosophila in cancer research: the first fifty tumor suppressor genes
1994
Detection of Isolated Tumor Cells in Bone Marrow Is an Independent Prognostic Factor in Breast Cancer
2003
Detection of Micrometastatic Disease and Monitoring of Perioperative Tumor Cell Dissemination in Primary Operable Breast Cancer Patients Using Real-Time Quantitative Reverse Transcription-PCR
2004
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
2001 Standout
Lack of Effect of Adjuvant Chemotherapy on the Elimination of Single Dormant Tumor Cells in Bone Marrow of High-Risk Breast Cancer Patients
2000
Impaired wound healing in mice with a disrupted plasminogen gene
1996
CTLA-4 blockade synergizes with tumor-derived granulocyte– macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma
1998 StandoutNobel
Integrins: Versatility, modulation, and signaling in cell adhesion
1992 Standout
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
The Human Immunodeficiency Virus: Infectivity and Mechanisms of Pathogenesis
1988 StandoutScience
Simultaneous Immunohistochemical Detection of Tumor Cells in Lymph Nodes and Bone Marrow Aspirates in Breast Cancer and Its Correlation With Other Prognostic Factors
2001
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Molecular Detection of Cytokeratin-19–Positive Cells in the Peripheral Blood of Patients With Operable Breast Cancer: Evaluation of Their Prognostic Significance
2002
Drug Discovery: A Historical Perspective
2000 StandoutScience
Wound Healing--Aiming for Perfect Skin Regeneration
1997 StandoutScience
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Clinical Significance of Immunocytochemical Detection of Tumor Cells Using Digital Microscopy in Peripheral Blood and Bone Marrow of Breast Cancer Patients
2004
Pathogenesis of human immunodeficiency virus infection
1993
In vivo priming of two distinct antitumor effector populations: the role of MHC class I expression.
1994
Cyclooxygenase-2–Dependent Regulation of E-Cadherin: Prostaglandin E2 Induces Transcriptional Repressors ZEB1 and Snail in Non–Small Cell Lung Cancer
2006
Association of uPA, PAI-1, and uPAR in Nipple Aspirate Fluid (NAF) with Breast Cancer
2003
Predictive and Prognostic Value of Peripheral Blood Cytokeratin-19 mRNA-Positive Cells Detected by Real-Time Polymerase Chain Reaction in Node-Negative Breast Cancer Patients
2006
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
2002 StandoutScience
Detection and characterization of carcinoma cells in the blood
1998
Fission yeast orb 6, a ser/thr protein kinase related to mammalian rho kinase and myotonic dystrophy kinase, is required for maintenance of cell polarity and coordinates cell morphogenesis with the cell cycle
1998 StandoutNobel
Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC
1997 StandoutScience
Capture of Viable Circulating Tumor Cells in the Liver of Colorectal Cancer Patients
2013
Pathogenesis of Infection with Human Immunodeficiency Virus
1987
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Loss of E-Cadherin-Dependent Cell-Cell Adhesion due to Mutation of the β-Catenin Gene in a Human Cancer Cell Line, HSC-39
1995
Comparative Analysis of Micrometastasis to the Bone Marrow and Lymph Nodes of Node-Negative Breast Cancer Patients Receiving No Adjuvant Therapy
2001
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors
1999
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
Enhancement of Antitumor Immunity by CTLA-4 Blockade
1996 StandoutScienceNobel
Detection of Breast Cancer Cells in the Bone Marrow or Peripheral Blood: Methods and Prognostic Significance
2000
Dendritic Cells Exposed to Human Immunodeficiency Virus Type-1 Transmit a Vigorous Cytopathic Infection to CD4 + T Cells
1992 StandoutScienceNobel
Circulating Tumor Cells and Bone Marrow Micrometastasis
2008
Apoptosis in AIDS
1993 StandoutScienceNobel
Elicitation of structure-specific antibodies by epitope scaffolds
2010 StandoutNobel
Works of I. Funke being referenced
Individual development and uPA–receptor expression of disseminated tumour cells in bone marrow: A reference to early systemic disease in solid cancer
1995
Differential Expression of Proliferation-Associated Molecules in Individual Micrometastatic Carcinoma Cells
1993
Comparative analyses of bone marrow micrometastases in breast and gastric cancer
1996
Estrogen Receptor Expression Profile of Disseminated Epithelial Tumor Cells in Bone Marrow of Breast Cancer Patients
2003
Meta-analyses of studies on bone marrow micrometastases: an independent prognostic impact remains to be substantiated.
1998
Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial.
1998
Micrometastatic tumour cells in bone marrow of patients with gastric cancer: Methodological aspects of detection and prognostic significance
1991
Mikrometastasen im Knochenmark von Patienten mit Karzinomen des Kopf-Hals-Bereiches *,**
1994
Prognostic significance of bone marrow micrometastases in patients with gastric cancer.
1996
The epithelial cell surface antigen 17–1A, a target for antibody‐mediated tumor therapy: Its biochemical nature, tissue distribution and recognition by different monoclonal antibodies
1986
Prognostic Significance of ‘Micrometastases’
1995
The cellular receptor (CD4) of the human immunodeficiency virus is expressed on neurons and glial cells in human brain.
1987
E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration.
1993
Glycoprotein P3.58, associated with tumor progression in malignant melanoma, is a novel leukocyte activation antigen
1988
Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies.
1987
[Detection of tumor cells in bone marrow: a deciding aid for adjuvant therapy in node negative patients with breast cancer. Concept for a multicenter study and results of the pilot phase].
1991
Frequent down-regulation of major histocompatibility class I antigen expression on individual micrometastatic carcinoma cells.
1991